AHCO — AdaptHealth Corp.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1725255 ·
Last close
$5.64
Market Cap
$752.43M
52W High
$13.43
52W Low
$5.21
ADV30
2,730,233
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 567,533,000 | -68,568,000 | 165,000 | -133,929,000 | 4,340,869,000 | 43,289,000 | 2,954,613,000 |
| Mar 2026 | 614,322,000 | -93,976,000 | 5,489,000 | -16,040,000 | 4,424,007,000 | 47,964,000 | 2,909,526,000 |
| Dec 2025 | 1,469,945,000 | 795,817,000 | 34,139,000 | -102,770,000 | 4,316,577,000 | 106,136,000 | 2,790,253,000 |
| Sep 2025 | 602,630,000 | -55,742,000 | 67,130,000 | 24,509,000 | 4,383,523,000 | 80,357,000 | 2,758,672,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$583,274,000
Investing CF
$-624,379,000
Financing CF
$15,764,000
CapEx
$-485,594,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.71
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-782,941,000
Inventory
$105,480,000
Receivables
$390,389,000
ST Investments
—
EBIT TTM
$-145,458,000
Pretax Income TTM
$-247,082,000
Interest Exp TTM
$101,624,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,363,389,952
EBITDA
$583,473,024
Free Cash Flow
$-80,691,504
Enterprise Value
$2,838,049,536
Total Cash
$43,289,000
Total Debt
$2,065,088,000
Shares Out
133,409,161
Trailing EPS
$-1.71
Book Value
$10.34
ROE
-15.2%
ROA
2.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,244,857,000 | 186,266,000 | -70,794,000 | 4,316,577,000 | 2,790,253,000 | 1,518,562,000 | 601,771,000 |
| Dec 2024 | 3,260,975,000 | 276,810,000 | 90,422,000 | 4,486,947,000 | 2,908,829,000 | 1,571,145,000 | 541,839,000 |
| Dec 2023 | 3,200,177,000 | 232,386,000 | -678,895,000 | 4,508,650,000 | 3,041,981,000 | 1,458,454,000 | 480,666,000 |
| Dec 2022 | 2,970,595,000 | 190,411,000 | 69,316,000 | 5,219,587,000 | 3,061,829,000 | 2,151,158,000 | 373,867,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.13
Max Pain — expiry 2027-01-15
max pain strike: $7.50 · spot: $5.66 · call oi: 2,053 · put oi: 262
Expected Move to 2027-01-15:
±$1.67
(29.57%) —
implied range
$3.99 –
$7.34
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FLGT | Fulgent Genetics, Inc. | $610.84M | $22.20 | — |
| LMRI | Lumexa Imaging Holdings, Inc. | $980.93M | $10.21 | — |
| CSTL | CASTLE BIOSCIENCES INC | $1.09B | $35.81 | — |
| TDOC | Teladoc Health, Inc. | $1.11B | $6.09 | — |
| SBC | SBC Medical Group Holdings Inc | $503.95M | $4.90 | — |
News headlines (Yahoo Finance, 1h cache)
3 Reasons AHCO is Risky and 1 Stock to Buy Instead
2026-09-16 15:08 · Yahoo
AdaptHealth To Participate in Upcoming Investor Conferences
2026-09-11 17:00 · Yahoo
AdaptHealth Appoints Harriss Currie as Chief Financial Officer
2026-09-08 20:00 · Yahoo
Senior Health, Home Health & Hospice Stocks Q2 Recap: Benchmarking AdaptHealth (NASDAQ:AHCO)
2026-09-01 18:58 · Yahoo
5 Must-Read Analyst Questions From AdaptHealth’s Q2 Earnings Call
2026-08-13 03:17 · Yahoo
AdaptHealth (AHCO) Q2 2026 Earnings Call Transcript
2026-08-11 16:44 · Yahoo
AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth
2026-08-11 14:04 · Yahoo
Why AdaptHealth Stock Plummeted This Week
2026-08-09 17:13 · Yahoo
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
2026-08-07 20:05 · Yahoo
Cardinal Health Sees Growth Normalize as Specialty, At-Home Investments Expand
2026-09-19 16:02 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.